Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Micronized Alpha-Ketoglutarate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Prolyl and lysyl hydroxylases use alpha-ketoglutarate as the cosubstrate that is decarboxylated to succinate during each hydroxylation, and ascorbate keeps the enzyme's iron centre in the ferrous state so the cycle can continue. Neither works properly without the other. This is textbook collagen biochemistry rather than a claim from a combination trial.
Every enzyme that uses alpha-ketoglutarate as a cosubstrate carries a non-heme ferrous iron at its active site. Without adequate iron the cosubstrate cannot be used regardless of how much is supplied. The relationship is one of enzymatic requirement and is not an argument for taking iron without a measured need.
The first component of the alpha-ketoglutarate dehydrogenase complex requires thiamine pyrophosphate to decarboxylate the substrate. Low thiamine status stalls that step and alpha-ketoglutarate accumulates upstream. This is one of the clearest cofactor dependencies in the TCA cycle.
Dihydrolipoyl dehydrogenase, the third component of the alpha-ketoglutarate dehydrogenase complex, carries a flavin adenine dinucleotide group derived from riboflavin. It reoxidises the lipoamide arm so the complex can turn over again. Riboflavin status therefore sits directly on the throughput of this reaction.
Lipoic acid is covalently attached to the E2 subunit and shuttles the succinyl group between active sites within the complex. It is an integral part of the machinery that consumes alpha-ketoglutarate. Whether supplemental lipoic acid adds to endogenously synthesised lipoamide is a separate and unsettled question, so this is mechanistic rather than a dosing recommendation.
Conversion of alpha-ketoglutarate to succinyl-CoA reduces NAD+ to NADH, so the reaction depends on a supply of oxidised NAD+. Niacin and related precursors feed that pool. The link is stoichiometric biochemistry and says nothing on its own about a measured benefit from taking the two together.
Aminotransferases use pyridoxal-5-phosphate to move an amino group from an amino acid onto alpha-ketoglutarate, producing glutamate. That reaction is the main way alpha-ketoglutarate participates in nitrogen handling. Without adequate B6 the transamination step slows regardless of substrate supply.
Glutamine is deamidated to glutamate, and glutamate is converted to alpha-ketoglutarate by glutamate dehydrogenase or by transamination. The two sit on the same short pathway in both directions. Supplying one changes the pool size of the other, which is why they are often formulated together.
Arginine alpha-ketoglutarate pairs the two in one molecule, so a serving delivers both regardless of intent. The pairing began as a formulation convenience in sports products rather than as a demonstrated combination effect. Anyone counting arginine intake should count what the salt contributes.
Ornithine alpha-ketoglutarate has a long history in clinical nutrition, where the two components feed glutamine synthesis and urea cycle nitrogen handling from different directions. The salt is a delivery decision as much as a pharmacological one. Read the pairing as formulation convention plus overlapping nitrogen metabolism.
Most alpha-ketoglutarate sold for general use is the calcium salt, chosen for stability and handling over the hygroscopic free acid. A gram of the salt therefore carries a meaningful calcium load that adds to daily intake. That contribution belongs in a total calcium count and is rarely declared prominently.
Collagen peptides supply proline and glycine as building blocks, while alpha-ketoglutarate is the cosubstrate consumed when prolyl hydroxylase converts proline residues to hydroxyproline. Ascorbate and ferrous iron complete the same enzyme system. The pathway logic for combining them is sound, and a trial showing the combination outperforms collagen peptides alone has not been done.
Proline residues in the nascent collagen chain are the target of prolyl hydroxylase, and each hydroxylation consumes one molecule of alpha-ketoglutarate. Substrate and cosubstrate therefore move through the same reaction in fixed ratio. This describes the chemistry of collagen maturation, not a measured outcome in skin or joints.
Glycine occupies every third position in the collagen helix, so it is required in quantity wherever collagen is being assembled. It sits alongside the proline and hydroxyproline chemistry that alpha-ketoglutarate supports. The combination is about supplying a complete set of inputs rather than about one enhancing the other.
Nothing specific on file for Micronized Alpha-Ketoglutarate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.